Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

被引：0

作者：

Olga Millán

Mercé Brunet

Jaume Martorell

Felipe García

Elena Vidal

Isabel Rojo

Montserrat Plana

Teresa Gallart

Tomas Pumarola

Jose M. Miró

Jose M. Gatell

机构：

[1] Universitat de Barcelona,Servei Immunologia, Hospital Clínic, IDIBAPS

[2] Universitat de Barcelona,Servei Toxicologia, Hospital Clínic, IDIBAPS

[3] Universitat de Barcelona,Servei Infeccions, Hospital Clínic, IDIBAPS

[4] Universitate de Barcelona,Servei Microbiologia, Hospital Clínic, IDIBAPS

[5] Hospital Clinic de Barcelona,Servei Immunologia

来源：

Clinical Pharmacokinetics | 2005年 / 44卷

关键词：

Viral Load; Efavirenz; Mycophenolate Mofetil; Abacavir; Mycophenolic Acid;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：525 / 538

页数：13

共 50 条

[21] Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients
Villani, P
Regazzi, MB
Castelli, F
Viale, P
Torti, C
Seminari, E
Maserati, R
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (05) : 712 - 715
[22] Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients
Hsue, Priscilla Y.
Hunt, Peter W.
Wu, Yuaner
Schnell, Amanda
Ho, Jennifer E.
Hatano, Hiroyu
Xie, Yu
Martin, Jeffrey N.
Ganz, Peter
Deeks, Steven G.
AIDS, 2009, 23 (15) : 2021 - 2027
[23] Effect of Rifampicin on Efavirenz Pharmacokinetics in HIV-Infected Children With Tuberculosis
Ren, Yuan
Nuttall, James J. C.
Eley, Brian S.
Meyers, Tammy M.
Smith, Peter J.
Maartens, Gary
McIlleron, Helen M.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (05) : 439 - 443
[24] Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients
van der Lee, Manon
Sankatsing, Roaj
Schippers, Emile
Vogel, Martin
Faetkenheuer, Erd
van der Ven, Andre
Kroon, Frank
Rockstroh, Juegen
Wyen, Christoph
Baeumer, Anselm
de Root, Eric
Koopmans, Peter
Stroes, Erik
Reiss, Peter
Burger, David
ANTIVIRAL THERAPY, 2007, 12 (07) : 1127 - 1132
[25] Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir
Nolan, D
Upton, R
McKinnon, E
John, M
James, I
Adler, B
Roff, C
Vasikaran, S
Mallal, S
AIDS, 2001, 15 (10) : 1275 - 1280
[26] Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
Vispo, Eugenio
Barreiro, Pablo
Pineda, Juan A.
Mira, Jose A.
Maida, Ivana
Martin-Carbonero, Luz
Rodriguez-Novoa, Sonia
Santos, Ignacio
Lopez-Cortes, Luis F.
Merino, Dolores
Rivero, Antonio
Soriano, Vincent
ANTIVIRAL THERAPY, 2008, 13 (03) : 429 - 437
[27] Reasons for early abacavir discontinuation in HIV-infected patients
Peyriere, H
Guillemin, V
Lotthe, A
Baillat, V
Fabre, J
Favier, C
ANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1392 - 1397
[28] In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients
Falcinelli, Emanuela
Francisci, Daniela
Belfiori, Barbara
Petito, Eleonora
Guglielmini, Giuseppe
Malincarne, Lisa
Mezzasoma, AnnaMaria
Sebastiano, Manuela
Conti, Valentina
Giannini, Silvia
Bonora, Stefano
Baldelli, Franco
Gresele, Paolo
THROMBOSIS AND HAEMOSTASIS, 2013, 110 (02) : 349 - 357
[29] Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children
Capparelli, EV
Englund, JA
Connor, JD
Spector, SA
McKinney, RE
Palumbo, P
Baker, CJ
JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (02): : 133 - 140
[30] Pharmacometric Characterization of Efavirenz Developmental Pharmacokinetics and Pharmacogenetics in HIV-Infected Children
Salem, Ahmed Hamed
Fletcher, Courtney V.
Brundage, Richard C.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 136 - 143

← 1 2 3 4 5 →